Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Aevi Genomic Medicine Inc, Medical Devices Deals, 2011 to YTD 2017 10
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Medgenics Enters into Agreement with Kyowa Hakko Kirin 12
Medgenics Enters into Agreement with Harvard University 13
Medgenics Extends Co-Development Agreement With Baxter Healthcare 14
Licensing Agreements 15
NeuroFix Therapeutics Enters into Licensing Agreement with Lipopharma Therapeutics 15
Medgenics Enters into Licensing Agreement with Stanford University 16
Aevi Genomic Medicine Amends its Agreement with Children’s Hospital of Philadelphia 17
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 18
Equity Offering 19
Aevi Genomic Medicine Plans to Raise Funds in Secondary Offering of Shares 19
Aevi Genomic Medicine to Raise USD28 Million in Private Placement of Shares and Warrrants 20
Medgenics Raises USD20 Million in Public Offering of Shares 21
Medgenics Raises USD46 Million in Public Offering of Shares 23
Medgenics Raises USD24.2 Million in Public Offering of Shares 25
Medgenics Completes Underwriters’ Exercise Of Over-Allotment Option For Public Offering Of Shares For US$32.5 Million 27
Medgenics Completes Private Placement Of Units For US$9.5 Million 29
Medgenics Issues Additional Shares Upon Partial Exercise Of Underwriter’s Over Allotment Option 30
Acquisition 32
Medgenics Acquires NeuroFix Therapeutics 32
Aevi Genomic Medicine Inc – Key Competitors 33
Aevi Genomic Medicine Inc – Key Employees 34
Aevi Genomic Medicine Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Nov 02, 2017: Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results 36
Aug 09, 2017: Aevi Genomic Medicine Reports Second Quarter 2017 Financial Results 37
May 10, 2017: Aevi Genomic Medicine Announces First Quarter 2017 Operating Results 38
May 10, 2017: Aevi Genomic Medicine Q1 net loss decreases 39
Mar 09, 2017: Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update 40
Nov 03, 2016: Medgenics Reports Third Quarter 2016 Financial Results 42
Aug 04, 2016: Medgenics Reports Second Quarter 2016 Financial Results 44
May 10, 2016: Medgenics Reports First Quarter 2016 Financial Results and NFC-1 Program Update 45
Feb 17, 2016: Medgenics Reports Fourth Quarter and Full Year 2015 Results and Advancement of NFC-1 Development Programs 47
Corporate Communications 50
Dec 04, 2017: Aevi Genomic Medicine Announces New Appointment to its Board of Directors 50
Oct 10, 2016: Medgenics to Begin Trading on NASDAQ Global Market 51
Feb 03, 2016: Medgenics Promotes Brian Piper to Chief Financial Officer 52
Product News 53
10/29/2016: Medgenics Presents New Data Showing Prevalence of Genetic Mutations in Pediatric Populations with Attention Deficit Hyperactivity Disorder 53
Other Significant Developments 54
Dec 15, 2016: Medgenics Announces Name Change to Aevi Genomic Medicine 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Aevi Genomic Medicine Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Aevi Genomic Medicine Inc, Medical Devices Deals, 2011 to YTD 2017 10
Aevi Genomic Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Medgenics Enters into Agreement with Kyowa Hakko Kirin 12
Medgenics Enters into Agreement with Harvard University 13
Medgenics Extends Co-Development Agreement With Baxter Healthcare 14
NeuroFix Therapeutics Enters into Licensing Agreement with Lipopharma Therapeutics 15
Medgenics Enters into Licensing Agreement with Stanford University 16
Aevi Genomic Medicine Amends its Agreement with Children's Hospital of Philadelphia 17
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 18
Aevi Genomic Medicine Plans to Raise Funds in Secondary Offering of Shares 19
Aevi Genomic Medicine to Raise USD28 Million in Private Placement of Shares and Warrrants 20
Medgenics Raises USD20 Million in Public Offering of Shares 21
Medgenics Raises USD46 Million in Public Offering of Shares 23
Medgenics Raises USD24.2 Million in Public Offering of Shares 25
Medgenics Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$32.5 Million 27
Medgenics Completes Private Placement Of Units For US$9.5 Million 29
Medgenics Issues Additional Shares Upon Partial Exercise Of Underwriter's Over Allotment Option 30
Medgenics Acquires NeuroFix Therapeutics 32
Aevi Genomic Medicine Inc, Key Competitors 33
Aevi Genomic Medicine Inc, Key Employees 34
Aevi Genomic Medicine Inc, Subsidiaries 35